Proton pump inhibitors induce changes in the gut microbiome composition of systemic lupus erythematosus patients
Background: Currently, few studies focus on the association between gut microbiota and systemic lupus erythematosus (SLE), and much less studies consider the effect of drug usage. Proton pump inhibitors (PPIs) are commonly used to treat drug-related gastrointestinal damage in SLE patients. Therefore...
Main Authors: | Cao, N.-W (Author), Chu, X.-J (Author), Fan, Y.-G (Author), Fang, X.-Y (Author), Li, B.-Z (Author), Li, X.-B (Author), Wang, H. (Author), Ye, D.-Q (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central Ltd
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
The role of gut microbiota in systemic lupus erythematosus
by: Mu, Qinghui
Published: (2018) -
Gut Microbiome and Metabolites in Systemic Lupus Erythematosus: Link, Mechanisms and Intervention
by: Lingshu Zhang, et al.
Published: (2021-07-01) -
Clinical Significance of Changes in Gut Microbiome Associated with Use of Proton Pump Inhibitors
by: Tae Jun Kim, et al.
Published: (2020-09-01) -
Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus
by: Mengchen Guo, et al.
Published: (2020-11-01) -
Gut microbiota promote the inflammatory response in the pathogenesis of systemic lupus erythematosus
by: Yiyangzi Ma, et al.
Published: (2019-08-01)